{
    "Trade/Device Name(s)": [
        "BioFire COVID-19 Test 2",
        "BioFire\u00ae COVID-19 Test 2"
    ],
    "Submitter Information": "BioFire Defense, LLC",
    "510(k) Number": "K221460",
    "Predicate Device Reference 510(k) Number(s)": [
        "K211079"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QQX"
    ],
    "Summary Letter Date": "May 18, 2022",
    "Summary Letter Received Date": "May 19, 2022",
    "Submission Date": "May 18, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-CoV-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "SARS-CoV-2 RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Transport medium",
        "Saline"
    ],
    "Instrument(s)/Platform(s)": [
        "BioFire FilmArray 2.0",
        "BioFire FilmArray Torch"
    ],
    "Method(s)/Technology(ies)": [
        "Nested multiplex RT-PCR",
        "High resolution melting analysis"
    ],
    "Methodologies": [
        "RT-PCR",
        "Nucleic acid amplification",
        "Multiplex testing"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BioFire COVID-19 Test 2 qualitative nested multiplexed RT-PCR for detection of SARS-CoV-2 RNA in nasopharyngeal swabs using FilmArray instruments",
    "Indications for Use Summary": "Qualitative detection of nucleic acids from SARS-CoV-2 in nasopharyngeal swabs from symptomatic individuals suspected of COVID-19 by their healthcare provider using BioFire FilmArray systems",
    "fda_folder": "Microbiology"
}